Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for Migraine Aura Prophylaxis (ASIC Channels and Migraine Disease)
2024-516044-25-00Phase 3Authorised
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of amiloride in migraine with aura, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Number of seizures with aura, with or without headache. Planned start Oct 2024; status: authorised.
02
Drugs
amiloride
03
Conditions
migraine with aura
Beyond the preview
Go deeper on 2024-516044-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516044-25-00.